CD147 is a Novel Interaction Partner of Integrin αMβ2 Mediating Leukocyte and Platelet Adhesion
出版年份 2020 全文链接
标题
CD147 is a Novel Interaction Partner of Integrin αMβ2 Mediating Leukocyte and Platelet Adhesion
作者
关键词
-
出版物
Biomolecules
Volume 10, Issue 4, Pages 541
出版商
MDPI AG
发表日期
2020-04-02
DOI
10.3390/biom10040541
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- β2 Integrins—Multi-Functional Leukocyte Receptors in Health and Disease
- (2020) Monika Bednarczyk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Platelet–Neutrophil Crosstalk in Atherothrombosis
- (2019) Joachim Pircher et al. THROMBOSIS AND HAEMOSTASIS
- Extracellular Matrix Metalloproteinase Inducer EMMPRIN (CD147) in Cardiovascular Disease
- (2018) Saskia von Ungern-Sternberg et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ligand-specific binding forces of LFA-1 and Mac-1 in neutrophil adhesion and crawling
- (2018) Ning Li et al. MOLECULAR BIOLOGY OF THE CELL
- Structural Immunology of Complement Receptors 3 and 4
- (2018) Thomas Vorup-Jensen et al. Frontiers in Immunology
- From leukocyte recruitment to resolution of inflammation: the cardinal role of integrins
- (2017) Ioannis Kourtzelis et al. JOURNAL OF LEUKOCYTE BIOLOGY
- S100A9 induces monocyte/ macrophage migration via EMMPRIN
- (2017) Vasileia Ismini Alexaki et al. THROMBOSIS AND HAEMOSTASIS
- Extracellular Cyclophilin A Augments Platelet-Dependent Thrombosis and Thromboinflammation
- (2017) Saskia von Ungern-Sternberg et al. THROMBOSIS AND HAEMOSTASIS
- Developmental endothelial locus-1 modulates platelet-monocyte interactions and instant blood-mediated inflammatory reaction in islet transplantation
- (2016) Jong-Hyung Lim et al. THROMBOSIS AND HAEMOSTASIS
- Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners
- (2015) Takashi Muramatsu JOURNAL OF BIOCHEMISTRY
- Leukocyte integrins: Role in leukocyte recruitment and as therapeutic targets in inflammatory disease
- (2015) Ioannis Mitroulis et al. PHARMACOLOGY & THERAPEUTICS
- Cyclophilin A and EMMPRIN (CD147) in cardiovascular diseases
- (2014) Peter Seizer et al. CARDIOVASCULAR RESEARCH
- Neutrophil cell surface receptors and their intracellular signal transduction pathways
- (2013) Krisztina Futosi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Intracellular cyclophilin A is an important Ca2+ regulator in platelets and critically involved in arterial thrombus formation
- (2012) M. Elvers et al. BLOOD
- S100A9 Is a Novel Ligand of EMMPRIN That Promotes Melanoma Metastasis
- (2012) T. Hibino et al. CANCER RESEARCH
- Endogenous modulators of inflammatory cell recruitment
- (2012) George Hajishengallis et al. TRENDS IN IMMUNOLOGY
- Disrupting the EMMPRIN (CD147)–Cyclophilin A Interaction Reduces Infarct Size and Preserves Systolic Function After Myocardial Ischemia and Reperfusion
- (2011) Peter Seizer et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- EMMPRIN and its ligand Cyclophilin A as novel diagnostic markers in inflammatory cardiomyopathy
- (2011) Peter Seizer et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Pro-inflammatory activities induced by CyPA–EMMPRIN interaction in monocytes
- (2010) Wei Yuan et al. ATHEROSCLEROSIS
- EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation
- (2009) Peter Seizer et al. ATHEROSCLEROSIS
- The interaction of HAb18G/CD147 with integrin α6β1 and its implications for the invasion potential of human hepatoma cells
- (2009) Jing-yao Dai et al. BMC CANCER
- Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro
- (2009) Harald F. Langer et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interaction
- (2009) Peter Seizer et al. THROMBOSIS AND HAEMOSTASIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started